Product Code: ETC13344471 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Paediatric Vaccine Market was valued at USD 10 Billion in 2024 and is expected to reach USD 14.45 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The Global Paediatric Vaccine Market is a dynamic sector experiencing steady growth due to increasing awareness about the importance of vaccinations in preventing diseases among children. Key factors driving market growth include government initiatives for immunization programs, technological advancements in vaccine development, and rising incidences of infectious diseases. The market is characterized by a wide range of vaccines, including those for measles, polio, hepatitis, and influenza, among others. With a focus on preventive healthcare, pharmaceutical companies are investing heavily in research and development to introduce new and improved vaccines. North America and Europe are leading regions in terms of market share, followed by Asia Pacific and Latin America. The market is competitive, with key players such as GlaxoSmithKline, Pfizer, and Sanofi dominating the industry.
The global paediatric vaccine market is experiencing significant growth driven by increasing awareness about the importance of vaccination, rising government initiatives to expand immunization programs, and the introduction of new and advanced vaccines. Key trends in the market include the growing adoption of combination vaccines for improved convenience and compliance, the development of vaccines for emerging infectious diseases, and the expansion of vaccination coverage in developing countries. Opportunities in the market lie in the increasing focus on research and development for novel vaccines, the rising demand for personalized vaccines, and the potential for market expansion in untapped regions. Additionally, the growing prevalence of infectious diseases and the emphasis on preventive healthcare are expected to drive further growth in the paediatric vaccine market.
The Global Paediatric Vaccine Market faces several challenges, including the high cost of vaccine development and manufacturing, stringent regulatory requirements, and complex supply chain logistics for distribution to remote or underserved areas. Additionally, vaccine hesitancy among some parents and caregivers, driven by misinformation and lack of awareness about the importance of vaccination, poses a significant obstacle to achieving high immunization rates. Limited access to healthcare infrastructure in developing countries further hinders the delivery of vaccines to vulnerable populations. Furthermore, the need for continuous research and development to address emerging infectious diseases and adapt to evolving strains of pathogens adds to the complexity of the paediatric vaccine market. Collaboration among governments, pharmaceutical companies, healthcare providers, and advocacy groups is essential to overcome these challenges and ensure widespread vaccination coverage.
The Global Paediatric Vaccine Market is primarily driven by factors such as the increasing prevalence of infectious diseases among children, rising awareness about the importance of vaccination in preventing illnesses, government initiatives promoting immunization programs, and the introduction of advanced vaccines with improved efficacy and safety profiles. Additionally, the expanding pediatric population in emerging economies, growing investments in research and development for new vaccines, and the emphasis on routine vaccination schedules by healthcare providers are also contributing to the market growth. Furthermore, the ongoing efforts to address vaccine hesitancy and improve access to immunization services in underserved regions are expected to further propel the market expansion in the coming years.
Government policies related to the Global Paediatric Vaccine Market focus on ensuring the availability, affordability, and accessibility of vaccines for children worldwide. These policies include funding for research and development of new vaccines, procurement mechanisms to ensure supply continuity, vaccination programs to reach underserved populations, and regulatory frameworks to ensure safety and efficacy. Additionally, governments may implement mandates for childhood vaccinations to promote herd immunity and prevent the spread of infectious diseases. Collaboration between governments, international organizations, and vaccine manufacturers is crucial to address challenges such as vaccine hesitancy, supply chain disruptions, and disparities in access, ultimately aiming to improve public health outcomes for children globally.
The Global Paediatric Vaccine Market is expected to continue its growth trajectory in the coming years due to increasing awareness about the importance of immunization, government initiatives to expand vaccination programs, and advancements in vaccine technology. The market is projected to see a rise in demand for pediatric vaccines as emerging economies invest more in healthcare infrastructure and preventive care. Additionally, the ongoing research and development activities aimed at developing new and improved vaccines for children are likely to further drive market growth. However, challenges such as vaccine hesitancy, regulatory hurdles, and pricing pressures may impact the market dynamics. Overall, the Global Paediatric Vaccine Market is anticipated to expand steadily, with a focus on innovation and access to vaccines for children worldwide.
In the global paediatric vaccine market, Asia is poised to witness significant growth due to rising awareness about immunization programs and increasing government initiatives to improve vaccination coverage. North America leads the market with high adoption rates of paediatric vaccines and advanced healthcare infrastructure. Europe follows closely with a strong focus on research and development in the field of paediatric vaccines. The Middle East and Africa region is experiencing steady growth as governments invest in healthcare infrastructure and increase their vaccination coverage. Latin America is also showing positive growth trends driven by increasing healthcare expenditure and growing awareness about the importance of immunization among children. Overall, the global paediatric vaccine market is expected to witness continued growth across all regions due to rising prevalence of infectious diseases and increasing focus on preventative healthcare measures.
Global Paediatric Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Paediatric Vaccine Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Paediatric Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Global Paediatric Vaccine Market - Industry Life Cycle |
3.4 Global Paediatric Vaccine Market - Porter's Five Forces |
3.5 Global Paediatric Vaccine Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Paediatric Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Paediatric Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.8 Global Paediatric Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Paediatric Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Paediatric Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Paediatric Vaccine Market Trends |
6 Global Paediatric Vaccine Market, 2021 - 2031 |
6.1 Global Paediatric Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Paediatric Vaccine Market, Revenues & Volume, By Live Attenuated, 2021 - 2031 |
6.1.3 Global Paediatric Vaccine Market, Revenues & Volume, By Inactivated, 2021 - 2031 |
6.1.4 Global Paediatric Vaccine Market, Revenues & Volume, By Conjugate, 2021 - 2031 |
6.1.5 Global Paediatric Vaccine Market, Revenues & Volume, By Recombinant, 2021 - 2031 |
6.2 Global Paediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Paediatric Vaccine Market, Revenues & Volume, By MMR Vaccine, 2021 - 2031 |
6.2.3 Global Paediatric Vaccine Market, Revenues & Volume, By Polio Vaccine, 2021 - 2031 |
6.2.4 Global Paediatric Vaccine Market, Revenues & Volume, By Pneumococcal, 2021 - 2031 |
6.2.5 Global Paediatric Vaccine Market, Revenues & Volume, By Hepatitis B, 2021 - 2031 |
6.3 Global Paediatric Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Paediatric Vaccine Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
6.3.3 Global Paediatric Vaccine Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.3.4 Global Paediatric Vaccine Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.5 Global Paediatric Vaccine Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.4 Global Paediatric Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Paediatric Vaccine Market, Revenues & Volume, By Infants, 2021 - 2031 |
6.4.3 Global Paediatric Vaccine Market, Revenues & Volume, By Toddlers, 2021 - 2031 |
6.4.4 Global Paediatric Vaccine Market, Revenues & Volume, By Adolescents, 2021 - 2031 |
6.4.5 Global Paediatric Vaccine Market, Revenues & Volume, By Newborns, 2021 - 2031 |
7 North America Paediatric Vaccine Market, Overview & Analysis |
7.1 North America Paediatric Vaccine Market Revenues & Volume, 2021 - 2031 |
7.2 North America Paediatric Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Paediatric Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Paediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.5 North America Paediatric Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Paediatric Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Paediatric Vaccine Market, Overview & Analysis |
8.1 Latin America (LATAM) Paediatric Vaccine Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Paediatric Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Paediatric Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Paediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
8.5 Latin America (LATAM) Paediatric Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Paediatric Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Paediatric Vaccine Market, Overview & Analysis |
9.1 Asia Paediatric Vaccine Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Paediatric Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Paediatric Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Paediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
9.5 Asia Paediatric Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Paediatric Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Paediatric Vaccine Market, Overview & Analysis |
10.1 Africa Paediatric Vaccine Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Paediatric Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Paediatric Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Paediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
10.5 Africa Paediatric Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Paediatric Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Paediatric Vaccine Market, Overview & Analysis |
11.1 Europe Paediatric Vaccine Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Paediatric Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Paediatric Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Paediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
11.5 Europe Paediatric Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Paediatric Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Paediatric Vaccine Market, Overview & Analysis |
12.1 Middle East Paediatric Vaccine Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Paediatric Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Paediatric Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Paediatric Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Paediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
12.5 Middle East Paediatric Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Paediatric Vaccine Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Paediatric Vaccine Market Key Performance Indicators |
14 Global Paediatric Vaccine Market - Export/Import By Countries Assessment |
15 Global Paediatric Vaccine Market - Opportunity Assessment |
15.1 Global Paediatric Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Paediatric Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Paediatric Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
15.4 Global Paediatric Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Paediatric Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Paediatric Vaccine Market - Competitive Landscape |
16.1 Global Paediatric Vaccine Market Revenue Share, By Companies, 2024 |
16.2 Global Paediatric Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |